Course Innovation Value

HOW TO EVALUATE, DEMONSTRATE AND PROTECT THE VALUE OF LIFE SCIENCE INNOVATIONS
– a Course in Strategic Health Economics, Landscape Analysis and Intellectual Property

Research and development give biotech companies opportunities to create new treatment options in the form of therapies and diagnostics. For biotech companies, it is crucial to understand early on the health-economic value of an intervention, how market and environmental factors affect commercializability, and how patent protection and IP strategies protect that value. Growing demands from investors, healthcare providers, and authorities mean that professionals in the life sciences need knowledge of these issues.

Target audience:

The course is aimed, among others, at founders, project managers, business developers, clinical strategists and researchers in life science companies, as well as advisers and investors working with pre-clinical or early clinical projects.

Purpose:

To provide practical and hands-on knowledge in:
• basic health economics and how health-economic value is defined, measured and influences the commercial value of a research project,
• how to assess commercial feasibility through environmental analysis and identification of success factors,
• how patent protection is created and maintained, and risk management to preserve patent protection (IP value).

Course format:

The course combines lectures and discussions based on real-world cases and published material. All sessions are led by experienced instructors from the life science industry.

Contents:

Basics of health economics — What is value?
• Concepts: cost-effectiveness, QALY, patient value and willingness to pay.
• Why assessing an intervention’s value is important already in the early phase.

Practical estimation of health-economic value
• Methods: cost–utility analyses, budget impact models, simple decision models for early assessment.
• Examples: exercises with hypothetical/real-life (e.g., diagnostics, orphan drugs, gene therapies).

Communicating value — Value propositions for different stakeholders
• How to formulate and present value to investors, partner companies, authorities and healthcare providers.

Environmental analysis and commercial feasibility
• Market and competition analysis: identify and prioritize the market’s real needs (willingness to pay).
• Case study of a project’s commercialization potential.

Patents and IP value for early biotech projects
• Conditions for patent protection: patentability requirements, strategic priorities.
• The process from application to granted patent.
• When IP value can be lost.
• Practical aspects of the patent process.

Workshop/discussion
• Create conditions for successful market entry by aligning IP strategy, environmental analysis and health economics for an early biotech project.

Instructors:

The course is led by experts from IHE and bulb Intelligence. The instructors have extensive knowledge of the life science industry’s needs and conditions regarding value assessment and commercialization.

Take aways from course:

• Understanding of how value is defined and quantified in healthcare.
• Understanding of how to communicate value to investors, authorities and healthcare providers.
• Understanding of analysis and identification of a project’s commercial conditions.
• Understanding of IP value and how to avoid common pitfalls.
• Documentation

Course details:

Date: May 19, 2026
Time: 9:00 AM–4:30 PM with registration from 8:30 AM
Location: Råbygatan 2 at IHE’s Lund office  Map
Course fee: SEK 7,500 excl. VAT
Registration deadline: May 5

For questions, please contact Jonas Hjelmgren